MedTrace Logo

The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer

NCT01310062 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1600

Last updated 2011-03-07

No results posted yet for this study

Summary

More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.

Conditions

  • Hepatitis B,Chronic
  • Carcinoma,Hepatocellular

Sponsors & Collaborators

  • GeneNews Sdn Bhd

    collaborator UNKNOWN

  • Ministry of Health, Malaysia

    lead OTHER_GOV

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-08-31
Completion
2012-08-31

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01310062 on ClinicalTrials.gov